Copyright
©The Author(s) 2019. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Hepatol. Jan 27, 2019; 11(1): 19-36
Published online Jan 27, 2019. doi: 10.4254/wjh.v11.i1.19
Published online Jan 27, 2019. doi: 10.4254/wjh.v11.i1.19
Treatment of primary sclerosing cholangitis in children
Trevor J Laborda, M Kyle Jensen, Marianne Kavan, Mark Deneau, Department of Pediatrics, University of Utah, Salt Lake City, UT 84113, United States
Author contributions: All authors contributed equally to the writing and editing of this review article.
Conflict-of-interest statement: The authors report no conflicts of interest.
Open-Access: This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Corresponding author: Mark Deneau, MD, MSc, Associate Professor, Department of Pediatrics, University of Utah, Salt Lake City, 81 North Mario Capecchi Drive, UT 84113, United States. mark.deneau@hsc.utah.edu
Telephone: +1-801-2133599 Fax: +1-801-5877539
Received: August 29, 2018
Peer-review started: August 29, 2018
First decision: October 8, 2018
Revised: December 19, 2018
Accepted: January 5, 2019
Article in press: January 6, 2019
Published online: January 27, 2019
Peer-review started: August 29, 2018
First decision: October 8, 2018
Revised: December 19, 2018
Accepted: January 5, 2019
Article in press: January 6, 2019
Published online: January 27, 2019
Core Tip
Core tip: This review provides an evidence-based framework for endoscopic and medical management of children with primary sclerosing cholangitis.